Evidence map›Paper›PMID 37541749›Full record

ArticleBMJ open2023

Correlates of

Karine Blouin, Brigitte Lefebvre, Annick Trudelle, Fannie Defay, Gentiane Perrault Sullivan, Léni Nina Débora Ezin Aloffan, Annie-Claude Labbé

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Karine BlouinDirection des risques biologiques, Institut national de santé publique du Québec, Québec, Québec, Canada karine.blouin@inspq.qc.ca.ORCID 0000-0002-6657-9874
Brigitte LefebvreLaboratoire de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.
Annick TrudelleDirection des risques biologiques, Institut national de santé publique du Québec, Québec, Québec, Canada.
Fannie DefayDirection des risques biologiques, Institut national de santé publique du Québec, Québec, Québec, Canada.
Gentiane Perrault SullivanDirection des risques biologiques, Institut national de santé publique du Québec, Québec, Québec, Canada.
Léni Nina Débora Ezin AloffanDirection des risques biologiques, Institut national de santé publique du Québec, Québec, Québec, Canada.
Annie-Claude LabbéDépartement de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, Québec, Canada.
Institut National de Santé Publique du Québec · CAHôpital Maisonneuve-Rosemont · CASte. Anne's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo examine correlates of DESIGN AND

settingThe sentinel surveillance network is an open cohort of gonococcal infection cases from Québec, Canada. Cross-sectional results are reported herein.

participantsBetween 1 January 2016 and 31 December 2019, data from 886 individuals accounting for 941 gonorrhoea cases were included.

methodsEpidemiological and clinical data were collected using an auto-administered questionnaire, direct case interviews and chart reviews. Antimicrobial susceptibility testing was performed using the agar dilution method. Generalised estimating equations were used for regression.

resultsThe prevalence of azithromycin resistance with a minimal inhibitory concentration (MIC) of ≥2 mg/L was 21.3%. In 2016, men who have sex with men were more likely to be infected with an azithromycin-resistant

conclusionSignificant correlates of

Indexed as

GonorrheaHIV InfectionsSexual and Gender MinoritiesAdultAnti-Bacterial AgentsAzithromycinCefiximeCeftriaxoneCiprofloxacinCross-Sectional StudiesDrug Resistance, BacterialFemaleHomosexuality, MaleHumansMaleMicrobial Sensitivity TestsAnti-Bacterial AgentsAzithromycinCefiximeCeftriaxoneCiprofloxacinepidemiologyinfection controlpublic health

Identifiers

PMID37541749
PMCPMC10407373
OpenAlexW4385575502

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.